Stachowicz K - Search Results

1

Early lifetime zinc supplementation protects zinc-deficient diet-induced alterations.

Opoka W, Sowa-Kućma M, Stachowicz K, Ostachowicz B, Szlósarczyk M, Stypuła A, Młyniec K, Maślanka A, Baś B, Lankosz M, Nowak G. Opoka W, et al. Among authors: stachowicz k. Pharmacol Rep. 2010 Nov-Dec;62(6):1211-7. doi: 10.1016/s1734-1140(10)70384-4. Pharmacol Rep. 2010. PMID: 21273680 Free article.

2

Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methyl-piperazin-1-yl)propyl] derivatives of 3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione.

Obniska J, Jurczyk S, Zejc A, Kamiński K, Tatarczyńska E, Stachowicz K. Obniska J, et al. Among authors: stachowicz k. Pharmacol Rep. 2005 Mar-Apr;57(2):170-5. Pharmacol Rep. 2005. PMID: 15886415 Free article.

3

Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats.

Stachowicz K, Kłak K, Pilc A, Chojnacka-Wójcik E. Stachowicz K, et al. Pharmacol Rep. 2005 Nov-Dec;57(6):856-60. Pharmacol Rep. 2005. PMID: 16382208 Free article.

4

Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling.

Stachowicz K, Chojnacka-Wójcik E, Kłak K, Pilc A. Stachowicz K, et al. Pharmacol Rep. 2006 Nov-Dec;58(6):820-6. Pharmacol Rep. 2006. PMID: 17220539 Free article.

5

Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.

Stachowicz K, Gołembiowska K, Sowa M, Nowak G, Chojnacka-Wójcik E, Pilc A. Stachowicz K, et al. Neuropharmacology. 2007 Nov;53(6):741-8. doi: 10.1016/j.neuropharm.2007.08.002. Epub 2007 Aug 14. Neuropharmacology. 2007. PMID: 17870136

6

Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent.

Stachowicz K, Wierońska J, Domin H, Chaki S, Pilc A. Stachowicz K, et al. Pharmacol Rep. 2011;63(4):880-7. doi: 10.1016/s1734-1140(11)70603-x. Pharmacol Rep. 2011. PMID: 22001975 Free article.

7

Anxiolytic-like activity of zinc in rodent tests.

Partyka A, Jastrzębska-Więsek M, Szewczyk B, Stachowicz K, Sławińska A, Poleszak E, Doboszewska U, Pilc A, Nowak G. Partyka A, et al. Among authors: stachowicz k. Pharmacol Rep. 2011;63(4):1050-5. doi: 10.1016/s1734-1140(11)70621-1. Pharmacol Rep. 2011. PMID: 22001993 Free article.

8

Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. Part 5.

Gomółka A, Ciesielska A, Wróbel MZ, Chodkowski A, Kleps J, Dawidowski M, Siwek A, Wolak M, Stachowicz K, Sławińska A, Nowak G, Satała G, Bojarski AJ, Belka M, Ulenberg S, Bączek T, Skowronek P, Turło J, Herold F. Gomółka A, et al. Among authors: stachowicz k. Eur J Med Chem. 2015 Jun 15;98:221-36. doi: 10.1016/j.ejmech.2015.05.003. Epub 2015 May 9. Eur J Med Chem. 2015. PMID: 26043160

9

Concentration-Dependent Dual Mode of Zn Action at Serotonin 5-HT1A Receptors: In Vitro and In Vivo Studies.

Satała G, Duszyńska B, Stachowicz K, Rafalo A, Pochwat B, Luckhart C, Albert PR, Daigle M, Tanaka KF, Hen R, Lenda T, Nowak G, Bojarski AJ, Szewczyk B. Satała G, et al. Among authors: stachowicz k. Mol Neurobiol. 2016 Dec;53(10):6869-6881. doi: 10.1007/s12035-015-9586-3. Epub 2015 Dec 12. Mol Neurobiol. 2016. PMID: 26660328 Free PMC article.

10

Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT_1A receptor ligands.

Ślifirski G, Król M, Kleps J, Ulenberg S, Belka M, Bączek T, Siwek A, Stachowicz K, Szewczyk B, Nowak G, Bojarski A, Kozioł AE, Turło J, Herold F. Ślifirski G, et al. Among authors: stachowicz k. Eur J Med Chem. 2019 Mar 15;166:144-158. doi: 10.1016/j.ejmech.2019.01.031. Epub 2019 Jan 22. Eur J Med Chem. 2019. PMID: 30703658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page